The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Glucokinase and IRS-2 are required for compensatory cell hyperplasia in response to high-fat diet-induced insulin resistance
Open accessAbstract
Glucokinase (Gck) functions as a glucose sensor for insulin secretion, and in mice fed standard chow, haploinsufficiency of beta cell-specific Gck (Gck(+/-)) causes impaired insulin secretion to glucose, although the animals have a normal beta cell mass. When fed a high-fat (HF) diet, wild-type mice showed marked beta cell hyperplasia, whereas Gck(+/-) mice demonstrated decreased beta cell replication and insufficient beta cell hyperplasia despite showing a similar degree of insulin resistance. DNA chip analysis revealed decreased insulin receptor substrate 2 (Irs2) expression in HF diet-fed Gck(+/-) mouse islets compared with wild-type islets. Western blot analyses confirmed upregulated Irs2 expression in the islets of HF diet-fed wild-type mice compared with those fed standard chow and reduced expression in HF diet-fed Gck(+/-) mice compared with those of HF diet-fed wild-type mice. HF diet-fed Irs2(+/-) mice failed to show a sufficient increase in beta cell mass, and overexpression of Irs2 in beta cells of HF diet-fed Gck(+/-) mice partially prevented diabetes by increasing beta cell mass. These results suggest that Gck and Irs2 are critical requirements for beta cell hyperplasia to occur in response to HF diet-induced insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Self-citationKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80210-5 · Cited by 1,342
Self-citationAlternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252 · cited 2×
“For example, while both insulin receptor substrate 1 (IRS-1) knockout (Irs1–/–) mice (8, 9) and IRS-2 knockout (Irs2–/–) mice (10, 11) exhibit similar degrees of insulin resistance, Irs1–/– mice have normal glucose tolerance as a result of compensatory β cell hyperplasia, whereas Irs2–/– mice develop diabetes because…”
BackgroundMolecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
Tamemoto, H., Kadowaki, T., Tobe, K., Yagi, T., Sakura, H., Hayakawa, T., Terauchi, Y., Ueki, K., Kaburagi, Y., Satoh, S., et al. (1994) · Nature · doi:10.1038/372182a0 · Cited by 1,083
Self-citationAhlgren, U., Jonsson, J., Jonsson, L., Simu, K., & Edlund, H. (1998) · Genes & Development · doi:10.1101/gad.12.12.1763 · Cited by 918
Type 2 Diabetes-a Matter of ß-Cell Life and Death?
Rhodes, C. J. (2005) · Science · doi:10.1126/science.1104345 · Cited by 896
A Lesson in Metabolic Regulation Inspired by the Glucokinase Glucose Sensor Paradigm
Matschinsky, F. M. (1996) · Diabetes · doi:10.2337/diab.45.2.223 · Cited by 729
Kaneto, H., Kajimoto, Y., Miyagawa, J., Matsuoka, T., Fujitani, Y., Umayahara, Y., Hanafusa, T., Matsuzawa, Y., Yamasaki, Y., & Hori, M. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2398 · Cited by 712
Nakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Polonsky, K. S., Sturis, J., & Bell, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341207 · Cited by 595
Kitamura, T., Nakae, J., Kitamura, Y., Kido, Y., Biggs, W., Wright, C. V. E., White, M. F., Arden, K. C., & Accili, D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16857 · Cited by 580
cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2
Jhala, U. S., Canettieri, G., Screaton, R. A., Kulkarni, R. N., Krajewski, S., Reed, J., Walker, J., Lin, X., White, M., & Montminy, M. (2003) · Genes & Development · doi:10.1101/gad.1097103 · Cited by 543
Kubota, N., Tobe, K., Terauchi, Y., Eto, K., Yamauchi, T., Suzuki, R., Tsubamoto, Y., Komeda, K., Nakano, R., Miki, H., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1880 · Cited by 521
Self-citationRegulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα
Tuttle, R. L., Gill, N. S., Pugh, W., Lee, J.-P., Koeberlein, B., Furth, E. E., Polonsky, K. S., Naji, A., & Birnbaum, M. J. (2001) · Nature Medicine · doi:10.1038/nm1001-1133 · Cited by 511
Eto, K., Tsubamoto, Y., Terauchi, Y., Sugiyama, T., Kishimoto, T., Takahashi, N., Yamauchi, N., Kubota, N., Murayama, S., Aizawa, T., et al. (1999) · Science · doi:10.1126/science.283.5404.981 · Cited by 491
Self-citationAnalysis of high density expression microarrays with signed-rank call algorithms
Liu, W.-M., Mei, R., Di, X., Ryder, T. B., Hubbell, E., Dee, S., Webster, T. A., Harrington, C. A., Ho, M.-H., Baid, J., et al. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.12.1593 · Cited by 426
Terauchi, Y., Tsuji, Y., Satoh, S., Minoura, H., Murakami, K., Okuno, A., Inukai, K., Asano, T., Kaburagi, Y., Ueki, K., et al. (1999) · Nature Genetics · doi:10.1038/6023 · Cited by 399
Self-citationBernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C. M., & Permutt, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13785 · Cited by 382
Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C. M., & Permutt, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113785 · Cited by 332
SREBPs suppress IRS-2-mediated insulin signalling in the liver
Ide, T., Shimano, H., Yahagi, N., Matsuzaka, T., Nakakuki, M., Yamamoto, T., Nakagawa, Y., Takahashi, A., Suzuki, H., Sone, H., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1111 · Cited by 322
Metabolism of Glucose in the Islets of Langerhans
Matschinsky, F. M., & Ellerman, J. E. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93432-0 · Cited by 310
Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM?
Taylor, S. I., Accili, D., & Imai, Y. (1994) · Diabetes · doi:10.2337/diab.43.6.735 · Cited by 289
Velho, G., Blanché, H., Vaxillaire, M., Bellanné-Chantelot, C., Pardini, V. C., Timsit, J., Passa, P., Deschamps, I., Robert, J.-J., Weber, I. T., et al. (1997) · Diabetologia · doi:10.1007/s001250050666 · Cited by 266
Freemark, M. (2002) · Endocrinology · doi:10.1210/en.143.4.1378 · Cited by 258 · cited 1×
“17, 18); tyrosine kinase pathways including the insulin receptor (Insr) (19), Igf1 receptor (Igf1r) (19), Irs2 (10, 11), and Akt (20, 21) pathways; the prolactin signaling pathway (22); and Hgf (23) have been reported to be implicated in β cell growth; however, coordinated regulation of β cell mass by these factors un…”
BackgroundTotal insulin and IGF-I resistance in pancreatic β cells causes overt diabetes
Ueki, K., Okada, T., Hu, J., Liew, C. W., Assmann, A., Dahlgren, G. M., Peters, J. L., Shackman, J. G., Zhang, M., Artner, I., et al. (2006) · Nature Genetics · doi:10.1038/ng1787 · Cited by 257
Garcia-Ocaña, A., Takane, K. K., Syed, M. A., Philbrick, W. M., Vasavada, R. C., & Stewart, A. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1226 · Cited by 247
Perspective: Postnatal Pancreatic β Cell Growth
Bonner-Weir, S. (2000) · Endocrinology · doi:10.1210/endo.141.6.7567 · Cited by 247
Insulin receptor substrate 2 plays a crucial role in β cells and the hypothalamus
Kubota, N., Terauchi, Y., Tobe, K., Yano, W., Suzuki, R., Ueki, K., Takamoto, I., Satoh, H., Maki, T., Kubota, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21484 · Cited by 239
Self-citationPancreatic β-Cell-specific Targeted Disruption of Glucokinase Gene
Terauchi, Y., Sakura, H., Yasuda, K., Iwamoto, K., Takahashi, N., Ito, K., Kasai, H., Suzuki, H., Ueda, O., Kamada, N., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30253 · Cited by 235
Self-citationAblation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β cell mass
Hashimoto, N., Kido, Y., Uchida, T., Asahara, S.-I., Shigeyama, Y., Matsuda, T., Takeda, A., Tsuchihashi, D., Nishizawa, A., Ogawa, W., et al. (2006) · Nature Genetics · doi:10.1038/ng1774 · Cited by 227
Watada, H., Kajimoto, Y., Umayahara, Y., Matsuoka, T.-A., Kaneto, H., Fujitani, Y., Kamada, T., Kawamori, R., & Yamasaki, Y. (1996) · Diabetes · doi:10.2337/diab.45.11.1478 · Cited by 221
Direct Comparison of GeneChip and SAGE on the Quantitative Accuracy in Transcript Profiling Analysis
Ishii, M., Hashimoto, S.-I., Tsutsumi, S., Wada, Y., Matsushima, K., Kodama, T., & Aburatani, H. (2000) · Genomics · doi:10.1006/geno.2000.6284 · Cited by 209
Self-citationMason, T. M., Goh, T., Tchipashvili, V, Sandhu, H., Gupta, N., Lewis, G. F., & Giacca, A. (1999) · Diabetes · doi:10.2337/diabetes.48.3.524 · Cited by 177
Terauchi, Y., Iwamoto, K., Tamemoto, H., Komeda, K., Ishii, C., Kanazawa, Y., Asanuma, N., Aizawa, T., Akanuma, Y., Yasuda, K., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119250 · Cited by 142
Self-citationRole of the forkhead protein FoxO1 in cell compensation to insulin resistance
Okamoto, H., Hribal, M. L., Lin, H. V., Bennett, W. R., Ward, A., & Accili, D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24967 · Cited by 135
Ikemoto, S., Thompson, K., Takahashi, M. M., Itakura, H., Lane, M. D., & Ezaki, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3096 · Cited by 118
New Insights into the Roles of Insulin/IGF-I in the Development and Maintenance of β-Cell Mass
Kulkarni, R. (2005) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-005-3051-y · Cited by 99
Shih, D. Q., Heimesaat, M. M., Kuwajima, S., Stein, R. W., Wright, C. V. E., & Stoffel, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062605899 · Cited by 97
IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication
Rhodes, C. J. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240303 · Cited by 93
Nonsense mutation of glucokinase gene in late-onset non-insulin-dependent diabetes mellitus
Katagiri, H., Asano, T., Ishihara, H., Inukai, K., Anai, M., Yazaki, Y., Oka, Y., & Miyazaki, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)92494-z · Cited by 68
Stone, L. M., Kahn, S. E., Fujimoto, W. Y., Deeb, S. S., & Porte, D. (1996) · Diabetes · doi:10.2337/diab.45.4.422 · Cited by 62
Pdx1 Expression in Irs2-deficient Mouse β-Cells Is Regulated in a Strain-dependent Manner
Suzuki, R., Tobe, K., Terauchi, Y., Komeda, K., Kubota, N., Eto, K., Yamauchi, T., Azuma, K., Kaneto, H., Taguchi, T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307004200 · Cited by 28
Self-citationAizawa, T., Asanuma, N., Terauchi, Y., Suzuki, N., Komatsu, M., Itoh, N., Nakabayashi, T., Hidaka, H., Ohnota, H., Yamauchi, K., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1826 · Cited by 25
Self-citation
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Osbak, K. K., Colclough, K., Saint-Martin, C., Beer, N. L., Bellanné-Chantelot, C., Ellard, S., & Gloyn, A. L. (2009) · Human Mutation · doi:10.1002/humu.21110 · Cited by 485
RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation
Yi, P., Park, J.-S., & Melton, D. A. (2013) · Cell · doi:10.1016/j.cell.2013.04.008 · Cited by 449
RetractedAssessing the potential of glucokinase activators in diabetes therapy
Matschinsky, F. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2850 · Cited by 401
Insulin-Like Signaling, Nutrient Homeostasis, and Life Span
Taguchi, A., & White, M. F. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100533 · Cited by 310
Metadata
- Authors
- Terauchi, Y., Takamoto, I., Kubota, N., Matsui, J., Suzuki, R., Komeda, K., Hara, A., Toyoda, Y., Miwa, I., Aizawa, S., Tsutsumi, S., Tsubamoto, Y., Hashimoto, S., Eto, K., Nakamura, A., Noda, M., Tobe, K., Aburatani, H., Nagai, R., & Kadowaki, T.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-01-02
- Volume
- 117
- Issue
- 1
- Pages
- 246-257
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2079088793
- Cited by
- 330
- References
- 49
- FWCI
- 28.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.